Trials / Conditions / Ovarian Serous Tumor
Ovarian Serous Tumor
6 registered clinical trials studyying Ovarian Serous Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Auranofin and Sirolimus in Treating Participants With Ovarian Cancer NCT03456700 | Mayo Clinic | Phase 2 |
| Completed | Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ova NCT03685695 | Roswell Park Cancer Institute | Phase 2 |
| Active Not Recruiting | Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, NCT02595892 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared NCT02446600 | National Cancer Institute (NCI) | Phase 3 |
| Withdrawn | Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent NCT02627430 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mas NCT02520115 | Barbara Ann Karmanos Cancer Institute | Phase 1 |